HGHCX Mutual Fund

NAV$26.58

Fund Essentials - as of Jan 31, 2026

Net Assets
$15M
Expense Ratio
2.07%
Dividend Yield (Current)
5.25%
Holdings
84
Inception Date
May 1, 2000
Fund Family
Hartford Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+4.62%
1 Year+34.10%
3 Year+8.48%
5 Year+5.81%
10 Year+14.01%

Asset Allocation

Stocks: 99.68%
Bonds: 0.19%
Cash: 0.14%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co13.12%
MRKMerck & Company Inc5.74%
JNJJohnson & Johnson5.07%
UNHUnitedhealth Group Incorporated4.64%
ABBVAbbvie Inc.3.84%
Top 10 Concentration: 47.48%Report Date: Jan 31, 2026
Download all 84 holdings for HGHCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
5.25%
Frequency
Annually
Latest Distribution
$4.37
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how HGHCX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

HGHCX Mutual Fund Overview

HGHCX Mutual Fund (The Hartford Healthcare Fund Class C) is managed by Hartford Funds with $15.5M in net assets. HGHCX expense ratio is 2.07%, holding 84 positions across sectors including Health Care, Unknown, Financials. Inception date: 2000-05-01.

HGHCX performance shows a YTD return of 4.62%. The 1-year return is 34.10% and the 5-year return is 5.81%. HGHCX dividend yield stands at 5.25%, paid annually.

HGHCX top holdings include Eli Lilly & Co (13.1%), Merck & Company Inc (5.7%), Johnson & Johnson (5.1%), Unitedhealth Group Incorporated (4.6%), Abbvie Inc. (3.8%). View all HGHCX holdings, sector breakdown, or dividend history.

HGHCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HGHCX alternatives are available via the screener, along with tax-loss harvesting opportunities.